Related references
Note: Only part of the references are listed.Collective ERK/Akt activity waves orchestrate epithelial homeostasis by driving apoptosis-induced survival
Paolo Armando Gagliardi et al.
DEVELOPMENTAL CELL (2021)
Current State of Target Treatment in BRAF Mutated Melanoma
Enrica Teresa Tanda et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma Cells
Luca Gerosa et al.
CELL SYSTEMS (2020)
Creating and screening natural product libraries
Brice A. P. Wilson et al.
NATURAL PRODUCT REPORTS (2020)
Thymol derivatives from the roots of Xerolekia speciosissima an endemic species of the pre-Alpine area
Natalia Kleczek et al.
PHYTOCHEMISTRY LETTERS (2019)
Methodology for the Absolute Configuration Determination of Epoxythymols Using the Constituents of Ageratina glabrata
Hector M. Arreaga-Gonzalez et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP-9 signaling pathway in DU145 cells
Yuan Zeng et al.
MOLECULAR MEDICINE REPORTS (2018)
Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
Paola M. Dantonio et al.
BIOSCIENCE REPORTS (2018)
mScarlet: a bright monomeric red fluorescent protein for cellular imaging
Daphne S. Bindels et al.
NATURE METHODS (2017)
Advances in the development of human protein microarrays
Jessica G. Duarte et al.
EXPERT REVIEW OF PROTEOMICS (2017)
Determination of the Absolute Configuration of Khellactone Esters from Peucedanum japonicum Roots
Min Jee Hong et al.
JOURNAL OF NATURAL PRODUCTS (2017)
Thymol inhibits cell migration and invasion by downregulating the activation of PI3K/AKT and ERK pathways in human colon cancer cells
Ran Lv et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2017)
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
Jessica Wagner et al.
CELL CYCLE (2017)
Overcoming resistance to BRAF inhibitors
Imanol Arozarena et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Mechanisms and Strategies to Overcome Resistance to Molecularly Targeted Therapy for Melanoma
Su Yin Lim et al.
CANCER (2017)
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
Zeynep Eroglu et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Targeting mutant NRAS signaling pathways in melanoma
Ha Linh Vu et al.
PHARMACOLOGICAL RESEARCH (2016)
Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance
Marieke I. G. Raaijmakers et al.
ONCOTARGET (2016)
A hyperactive piggyBac transposon system is an easy-to-implement method for introducing foreign genes into mouse preimplantation embryos
Shinnosuke Suzuki et al.
JOURNAL OF REPRODUCTION AND DEVELOPMENT (2015)
Consequences of feedback in signal transduction for targeted therapies
Bertram Klinger et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2014)
High-Sensitivity Measurements of Multiple Kinase Activities in Live Single Cells
Sergi Regot et al.
CELL (2014)
Combined Use of Extract Libraries and HPLC-Based Activity Profiling for Lead Discovery: Potential, Challenges, and Practical Considerations
Olivier Potterat et al.
PLANTA MEDICA (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
Hubing Shi et al.
CANCER DISCOVERY (2014)
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Eliezer M. Van Allen et al.
CANCER DISCOVERY (2014)
Tumor adaptation and resistance to RAF inhibitors
Piro Lito et al.
NATURE MEDICINE (2013)
A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum
Nathan C. Shaner et al.
NATURE METHODS (2013)
Relief of Profound Feedback Inhibition of Mitogenic Signaling by RAF Inhibitors Attenuates Their Activity in BRAFV600E Melanomas
Piro Lito et al.
CANCER CELL (2012)
Vemurafenib: the first drug approved for BRAF-mutant cancer
Gideon Bollag et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy
Ichiro Yajima et al.
DERMATOLOGY RESEARCH AND PRACTICE (2012)
Biology using engineering tools The negative feedback amplifier
Marc R. Birtwistle et al.
CELL CYCLE (2011)
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression
Yong Pil Hwang et al.
TOXICOLOGY LETTERS (2011)
HPLC-Based Activity Profiling: Discovery of Piperine as a Positive GABAA Receptor Modulator Targeting a Benzodiazepine-Independent Binding Site
Janine Zaugg et al.
JOURNAL OF NATURAL PRODUCTS (2010)
High-Throughput Screening of Natural Products for Cancer Therapy
Alan L. Harvey et al.
PLANTA MEDICA (2010)
V600EBRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway
Christine A. Pratilas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Analysis by HPLC and LC/MS of pungent piperamides in commercial black, white, green, and red whole and ground peppercorns
Mendel Friedman et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2008)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Thymol derivatives from hairy roots of Arnica montana
I. Weremczuk-Jezyna et al.
PLANT CELL REPORTS (2006)
Oncogenic BRAF is required for tumor growth and maintenance in melanoma models
MP Hoeflich et al.
CANCER RESEARCH (2006)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
B-RAF is a therapeutic target in melanoma
M Karasarides et al.
ONCOGENE (2004)
New amide alkaloids from the roots of Piper nigrum
K Wei et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Sesquiterpenes and monoterpenes from the bark of Inula macrophylla
BN Su et al.
JOURNAL OF NATURAL PRODUCTS (2001)
Share Paper
